Revenue declined 7.3% year-over-year to $474.5M in Q2 2026, but gross margin improved to 37.2% from 35.7% a year earlier, while operating margin held at 8.4% due to a 6.5% reduction in SG&A expenses.
ICF International, Inc. (ICFI) annual income statement — 22-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 |
|---|
| Sales/Revenue | 1.82B | 1.87B | 2.02B | 1.96B | 1.78B | 1.55B | 1.51B | 1.48B | 1.34B | 1.23B | 1.19B | 1.13B | 1.05B | 949.3M | 937.13M | 840.77M | 764.73M | 674.4M | 697.43M | 727.12M | 331.28M | 177.22M | 139.49M |
| Revenue Growth % | -7.89% | -7.27% | 2.88% | 10.3% | 14.61% | 3.06% | 1.92% | 10.5% | 8.85% | 3.72% | 4.67% | 7.82% | 10.62% | 1.3% | 11.46% | 9.94% | 13.39% | -3.3% | -4.08% | 119.49% | 86.93% | 27.05% | - |
| Cost of Goods Sold | 1.17B | 1.23B | 1.28B | 1.27B | 1.13B | 979.57M | 972.41M | 953.19M | 857.51M | 771.73M | 745.14M | 694.44M | 654.95M | 591.52M | 583.2M | 520.52M | 476.19M | 411.33M | 460M | 532.15M | 217.75M | 106.08M | 83.64M |
| COGS % of Revenue | - | 65.94% | 63.47% | 64.44% | 63.73% | 63.07% | 64.53% | 64.47% | 64.09% | 62.78% | 62.88% | 61.33% | 62.37% | 62.31% | 62.23% | 61.91% | 62.27% | 60.99% | 65.96% | 73.19% | 65.73% | 59.86% | 59.96% |
| Gross Profit | 649.05M | 637.87M | 737.77M | 698.22M | 645.54M | 573.48M | 534.47M | 525.34M | 480.46M | 457.44M | 439.96M | 437.8M | 395.19M | 357.79M | 353.94M | 320.25M | 288.55M | 263.06M | 237.42M | 194.97M | 113.53M | 71.14M | 55.85M |
| Gross Margin % | 35.64% | 34.06% | 36.53% | 35.56% | 36.27% | 36.93% | 35.47% | 35.53% | 35.91% | 37.22% | 37.12% | 38.67% | 37.63% | 37.69% | 37.77% | 38.09% | 37.73% | 39.01% | 34.04% | 26.81% | 34.27% | 40.14% | 40.04% |
| Gross Profit Growth % | - | -13.54% | 5.66% | 8.16% | 12.57% | 7.3% | 1.74% | 9.34% | 5.03% | 3.97% | 0.49% | 10.78% | 10.45% | 1.09% | 10.52% | 10.99% | 9.69% | 10.8% | 21.78% | 71.73% | 59.59% | 27.38% | - |
| Operating Expenses | 502.65M | 486.19M | 571.93M | 565.9M | 536.78M | 462.54M | 445.36M | 423.94M | 388.19M | 375.02M | 357.17M | 362.56M | 325.83M | 293.1M | 288.32M | 261.37M | 241.63M | 223.98M | 184.45M | 124.44M | 90.59M | 65.58M | 49.25M |
| OpEx % of Revenue | - | 25.96% | 28.32% | 28.82% | 30.16% | 29.78% | 29.56% | 28.67% | 29.01% | 30.51% | 30.14% | 32.02% | 31.03% | 30.88% | 30.77% | 31.09% | 31.6% | 33.21% | 26.45% | 17.11% | 27.35% | 37.01% | 35.31% |
| Selling, General & Admin | 476.68M | 492.4M | 518.45M | 496.56M | 486.86M | 430.57M | 411.61M | 395.76M | 360.99M | 346.44M | 328.05M | 329.16M | 302.02M | 272.39M | 263.88M | 241.06M | 218.53M | 203.43M | 170.36M | 118.13M | 87.06M | 60.04M | 46.1M |
| SG&A % of Revenue | - | 26.29% | 25.67% | 25.29% | 27.35% | 27.72% | 27.32% | 26.77% | 26.98% | 28.19% | 27.68% | 29.07% | 28.76% | 28.69% | 28.16% | 28.67% | 28.58% | 30.16% | 24.43% | 16.25% | 26.28% | 33.88% | 33.05% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 1000K | -6.22M | 53.48M | 69.34M | 49.92M | 31.97M | 33.75M | 28.18M | -735K | 121K | 1.18M | -1.56M | -958K | -12K | -325K | 20.31M | 23.1M | 20.55M | 14.09M | 6.32M | 3.54M | 5.54M | 3.15M |
| Operating Income | 146.4M | 151.68M | 165.84M | 132.32M | 108.76M | 110.94M | 89.11M | 101.39M | 92.27M | 82.42M | 82.79M | 75.23M | 69.36M | 64.69M | 65.62M | 58.88M | 46.91M | 39.08M | 52.97M | 70.52M | 22.94M | 5.56M | 6.6M |
| Operating Margin % | 8.04% | 8.1% | 8.21% | 6.74% | 6.11% | 7.14% | 5.91% | 6.86% | 6.9% | 6.71% | 6.99% | 6.64% | 6.61% | 6.81% | 7% | 7% | 6.13% | 5.8% | 7.6% | 9.7% | 6.92% | 3.14% | 4.73% |
| Operating Income Growth % | - | -8.54% | 25.33% | 21.66% | -1.96% | 24.49% | -12.12% | 9.88% | 11.96% | -0.45% | 10.05% | 8.46% | 7.23% | -1.42% | 11.44% | 25.52% | 20.03% | -26.22% | -24.88% | 207.42% | 312.59% | -15.73% | - |
| EBITDA | 181.12M | 209.83M | 219.32M | 193.06M | 158.68M | 142.91M | 120.55M | 128.33M | 119.48M | 111M | 111.91M | 108.64M | 93.17M | 85.4M | 90.06M | 79.19M | 70.01M | 59.64M | 67.06M | 76.84M | 26.48M | 11.1M | 9.75M |
| EBITDA Margin % | 9.95% | 11.2% | 10.86% | 9.83% | 8.91% | 9.2% | 8% | 8.68% | 8.93% | 9.03% | 9.44% | 9.59% | 8.87% | 9% | 9.61% | 9.42% | 9.16% | 8.84% | 9.62% | 10.57% | 7.99% | 6.26% | 6.99% |
| EBITDA Growth % | -16.46% | -4.33% | 13.6% | 21.67% | 11.04% | 18.55% | -6.06% | 7.41% | 7.64% | -0.82% | 3.01% | 16.6% | 9.1% | -5.17% | 13.73% | 13.11% | 17.4% | -11.07% | -12.72% | 190.22% | 138.5% | 13.82% | - |
| D&A (Non-Cash Add-back) | 41.83M | 58.15M | 53.48M | 60.74M | 49.92M | 31.97M | 31.44M | 26.93M | 27.21M | 28.58M | 29.12M | 33.41M | 23.81M | 20.71M | 24.44M | 20.31M | 23.1M | 20.55M | 14.09M | 6.32M | 3.54M | 5.54M | 3.15M |
| EBIT | 134M | 120.42M | 167.65M | 136.23M | 107.26M | 110.07M | 90.6M | 100.5M | 91.54M | 82.42M | 82.79M | 75.23M | 68.4M | 64.69M | 65.3M | 59.01M | 47.09M | 40.09M | 53.55M | 70.52M | 22.94M | 5.56M | 6.6M |
| Net Interest Income | -28.55M | -8.42M | -29.59M | -39.68M | -23.28M | -9.98M | -13.71M | -10.72M | -8.71M | -8.55M | -9.47M | -10.07M | -4.25M | -2.45M | -3.95M | -2.75M | -3.4M | -5.11M | -4.08M | -1.94M | -3.51M | -2.98M | -1.27M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 21.78M | 8.42M | 29.59M | 39.68M | 23.28M | 9.98M | 13.71M | 10.72M | 8.71M | 8.55M | 9.47M | 10.07M | 4.25M | 2.45M | 3.38M | 2.25M | 3.4M | 5.11M | 4.08M | 1.94M | 3.51M | 2.98M | 1.27M |
| Other Income/Expense | -34.18M | -39.69M | -27.78M | -35.77M | -24.78M | -10.85M | -14.44M | -11.22M | -9.45M | -8.43M | -8.29M | -11.63M | -5.21M | -2.46M | -3.71M | -2.12M | -3.23M | -4.1M | -3.5M | -1.43M | -2.86M | -1.67M | -1.3M |
| Pretax Income | 112.22M | 111.99M | 138.06M | 96.55M | 83.98M | 100.09M | 74.67M | 90.17M | 82.83M | 73.99M | 74.51M | 63.6M | 64.15M | 62.23M | 61.91M | 56.76M | 43.68M | 34.98M | 49.47M | 69.1M | 20.08M | 3.89M | 5.3M |
| Pretax Margin % | 6.16% | 5.98% | 6.84% | 4.92% | 4.72% | 6.44% | 4.96% | 6.1% | 6.19% | 6.02% | 6.29% | 5.62% | 6.11% | 6.55% | 6.61% | 6.75% | 5.71% | 5.19% | 7.09% | 9.5% | 6.06% | 2.19% | 3.8% |
| Income Tax | 23.67M | 20.41M | 27.89M | 13.94M | 19.74M | 28.96M | 19.71M | 21.23M | 21.43M | 11.11M | 27.92M | 24.23M | 24.12M | 22.9M | 23.84M | 21.89M | 16.51M | 12.63M | 20.75M | 28.54M | 8.21M | 1.86M | 2.47M |
| Effective Tax Rate % | 21.09% | 18.22% | 20.2% | 14.43% | 23.5% | 28.93% | 26.4% | 23.55% | 25.87% | 15.02% | 37.48% | 38.1% | 37.6% | 36.79% | 38.5% | 38.57% | 37.8% | 36.09% | 41.94% | 41.31% | 40.89% | 47.98% | 46.54% |
| Net Income | 88.55M | 91.59M | 110.17M | 82.61M | 64.24M | 71.13M | 54.96M | 68.94M | 61.4M | 62.88M | 46.58M | 39.37M | 40.03M | 39.33M | 38.08M | 34.87M | 27.17M | 22.36M | 28.72M | 40.56M | 11.87M | 2.02M | 3.02M |
| Net Margin % | 4.86% | 4.89% | 5.45% | 4.21% | 3.61% | 4.58% | 3.65% | 4.66% | 4.59% | 5.12% | 3.93% | 3.48% | 3.81% | 4.14% | 4.06% | 4.15% | 3.55% | 3.31% | 4.12% | 5.58% | 3.58% | 1.14% | 2.16% |
| Net Income Growth % | -17.82% | -16.86% | 33.36% | 28.59% | -9.68% | 29.43% | -20.28% | 12.28% | -2.35% | 34.97% | 18.33% | -1.65% | 1.78% | 3.3% | 9.21% | 28.32% | 21.54% | -22.17% | -29.18% | 241.75% | 486.89% | -32.98% | - |
| Net Income (Continuing) | 88.55M | 91.59M | 110.17M | 82.61M | 64.24M | 71.13M | 54.96M | 68.94M | 61.4M | 62.88M | 46.58M | 39.37M | 40.03M | 39.33M | 38.08M | 34.87M | 27.17M | 22.36M | 28.72M | 40.56M | 11.87M | 2.02M | 2.83M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 4.91 | 4.95 | 5.82 | 4.35 | 3.38 | 3.72 | 2.87 | 3.59 | 3.18 | 3.27 | 2.40 | 2.00 | 2.00 | 1.95 | 1.91 | 1.75 | 1.38 | 1.40 | 1.88 | 2.72 | 1.10 | 0.21 | 0.32 |
| EPS Growth % | -16% | -14.95% | 33.79% | 28.7% | -9.14% | 29.62% | -20.06% | 12.89% | -2.75% | 36.25% | 20% | 0% | 2.56% | 2.09% | 9.14% | 26.81% | -1.43% | -25.53% | -30.88% | 147.27% | 423.81% | -34.38% | - |
| EPS (Basic) | - | 4.98 | 5.88 | 4.39 | 3.41 | 3.77 | 2.92 | 3.66 | 3.27 | 3.35 | 2.45 | 2.04 | 2.04 | 1.99 | 1.94 | 1.77 | 1.40 | 1.45 | 1.96 | 2.87 | 1.15 | 0.22 | 0.33 |
| Diluted Shares Outstanding | 18.05M | 18.42M | 18.93M | 18.99M | 19.03M | 19.12M | 19.14M | 19.22M | 19.34M | 19.24M | 19.42M | 19.66M | 20M | 20.19M | 19.96M | 19.93M | 19.63M | 15.91M | 15.27M | 14.9M | 10.8M | 9.74M | 9.4M |
| Basic Shares Outstanding | 18.01M | 18.32M | 18.75M | 18.8M | 18.82M | 18.87M | 18.84M | 18.82M | 18.8M | 18.77M | 18.99M | 19.34M | 19.61M | 19.75M | 19.66M | 19.68M | 19.38M | 15.43M | 14.64M | 14.15M | 10.32M | 9.19M | 9.08M |
| Dividend Payout Ratio | - | 11.31% | 9.54% | 12.75% | 16.42% | 14.85% | 19.2% | 15.29% | 12.89% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quick answers to the most common questions about buying ICFI stock.
For fiscal year 2025, ICF International, Inc. (ICFI) reported total revenue of $1.87B. This represents a 1242.7% increase compared to $139.5M in 2004.
ICF International, Inc. (ICFI) is profitable, generating $91.6M in net income for the fiscal year ending 2025 with a net profit margin of 4.9%.
ICF International, Inc. (ICFI) reported an operating income of $151.7M, resulting in an operating profit margin of 8.1%. This margin reflects the operational efficiency of the business before interest and taxes.
ICF International, Inc. (ICFI) generated $637.9M in gross profit for the year, representing a gross profit margin of 34.1%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Revenue contraction and low cash
Metrics are mathematically derived from official filings.
Revenue Slide Reflects Contract Roll-Off
ICFI's revenue contracted 7.3% year-over-year in the latest quarter, with the decline accelerating from -0.3% in Q2 2026 to -10.3% in Q1 2026, per reported figures.
The revenue trajectory has been consistently negative over the past five quarters, with the most recent quarter showing a -0.3% YoY change, a slight improvement from the -10.3% in Q1 2026. This suggests the decline may be moderating, but the overall trend remains downward. The contraction appears driven by the roll-off of large contracts, possibly pandemic-related or disaster recovery work, as indicated by the company's profile. Investors should monitor the book-to-bill ratio and backlog trends to assess whether this is a temporary trough or a structural slowdown.
Gross Margin Resilience Amid Revenue Decline
Gross margin improved to 37.2% in Q2 2026 from 35.7% a year earlier, despite lower revenue, suggesting a favorable mix shift or cost controls, as per financial statements.
Gross margin has been relatively stable, ranging from 32.4% to 38.0% over the past ten quarters, with the latest quarter at 37.2%. The improvement in Q2 2026 compared to the prior year indicates that the company may be shedding lower-margin pass-through contracts, which aligns with the revenue decline. However, operating margin has remained flat around 8.4%, suggesting that SG&A costs have not scaled down proportionally with revenue, potentially reflecting fixed overhead costs. This could pressure margins if revenue continues to decline.
Operating Leverage Stalled by Fixed Costs
Operating income grew 0.0% YoY in Q2 2026 despite a 0.3% revenue decline, indicating limited operating leverage, as SG&A expenses remained nearly flat at $123.3M.
The company's operating leverage appears muted, as operating income has not expanded faster than gross profit. In Q2 2026, gross profit increased slightly YoY, but operating income was flat, implying that SG&A costs absorbed any incremental gross profit. This suggests a high fixed-cost base, typical of consulting firms with significant overhead. The lack of operating leverage means that any revenue growth may not translate into disproportionate profit growth, and conversely, revenue declines could hit operating income harder if costs are not adjusted.
EPS Volatility Masks Underlying Stability
Diluted EPS swung from $1.44 in Q1 2024 to $1.49 in Q2 2026, with a low of $0.94 in Q4 2025, reflecting tax and non-operating items, per income statement data.
Net income and EPS have been volatile, with EPS ranging from $0.94 to $1.73 over the past ten quarters. The Q2 2026 EPS of $1.49 was above the prior year's $1.28, but the Q1 2026 EPS of $1.12 was down 22.2% YoY. This volatility may be driven by tax rate changes, one-time items, or contract timing. Stock-based compensation has been relatively stable at around $4-5 million per quarter, which is not a major distortion. Investors should focus on operating income trends rather than net income, as the latter is subject to non-operating fluctuations.
SG&A Discipline Key to Margin Protection
SG&A expenses declined from $131.9M in Q1 2025 to $123.3M in Q2 2026, a 6.5% reduction, helping offset revenue declines and stabilize operating margins, per reported figures.
The company has shown cost discipline, with SG&A expenses trending down from a peak of $132.8M in Q3 2024 to $123.3M in Q2 2026. This reduction has helped maintain operating margins around 8.4% despite revenue contraction. However, the pace of SG&A reduction has not fully matched the revenue decline, as operating margin has remained flat rather than expanding. The primary cost driver is professional labor, which is variable but has fixed components. Management's ability to adjust staffing levels in response to demand will be critical for margin sustainability.
2024 Peak Marks Turning Point
Revenue peaked at $517.0M in Q3 2024, followed by a sustained decline to $474.5M in Q2 2026, a -8.2% drop, signaling a clear inflection point, as per quarterly data.
The third quarter of 2024 appears to be the peak of the recent cycle, with revenue of $517.0M and operating income of $46.0M, the highest in the ten-quarter period. Since then, revenue has declined in seven of the next eight quarters, with the only exception being a slight uptick in Q2 2026. This inflection likely reflects the completion of large contracts and a slowdown in new awards. The lasting impact is a lower revenue base, but the company has maintained profitability, suggesting that the decline may be in lower-margin work. The key question is whether the company can return to growth through new contract wins.
Revenue Decline Could Signal Structural Weakness
The persistent -7.3% TTM revenue decline and Q2 2026 EPS miss of $1.86 vs. $1.99 consensus suggest the contraction may be more than a temporary roll-off, per recent earnings.
Short-sellers would argue that the sustained revenue decline, combined with a recent EPS miss, indicates a loss of competitive position or a shrinking addressable market. The company's heavy reliance on civilian agencies like EPA and HHS makes it vulnerable to budget shifts, and the low cash position of $5.3 million could limit flexibility. While management maintained full-year guidance, the credibility of that guidance is questionable given the quarterly miss. If the revenue decline persists, operating leverage could work in reverse, compressing margins further. Investors should monitor backlog and new award announcements for signs of stabilization.